Where you start on your CLL journey matters.
Biomarker testing changed everything for Nathan, enabling him to find the right treatment for his needs. Watch his story to discover why biomarker testing before starting your CLL treatment journey—and retesting throughout—is critical for the most effective treatment plan.
Test Before Treat: Find the Right Chronic Lymphocytic Leukemia (CLL) Treatment for You
There’s no single treatment for CLL or small lymphocytic lymphoma (SLL) that’s right for everyone, but a blood test can help your doctor understand your unique biomarkers, guiding each treatment decision, revealing how aggressive the disease may become and how your body might react to certain medications.
Powered by our partnership with BeiGene, Test Before Treat is the most important step you can take to effectively manage your CLL, because where you start on your CLL journey matters. And how you live is everything.
Action Items
Why You Should “Test Before Treat”
The best treatment for CLL is the one that’s right for you – based on your unique genetic test results. Biomarker testing before initial treatment and retesting at each subsequent treatment may help ensure you get the best treatment at each stage of your CLL journey.
About 50% of CLL patients have high-risk genetic features that may limit the effectiveness of some treatments (e.g. chemotherapy) and increase the likelihood of disease progression. Knowing your specific disease profile will help you and your doctor decide on what may be the most effective treatment for you.
Did you know?
RESOURCES
CLL Experts Agree: Test Before Treat
Hear from top experts at leading research centers about the difference that biomarker testing can make in improving care for CLL patients.
Patient Stories: Why Testing Matters
Learn from CLL patients like Nathan who discovered how biomarker testing could make a difference in their unique treatment journey. Empowered by education and knowledge, patients can partner with their providers in shared decision making to ensure the most personalized and effective care plan.
Test Before Treat is powered by BeiGene, a global oncology company developing targeted therapies for CLL.
ADDITIONAL READING
QUICK LINKS
